Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

Similar articles for PubMed (Select 23913375)

1.

Vascular endothelial growth factor +936C/T polymorphism and cancer risk in Asians: a meta-analysis.

Liu XL, Yang QF, Kong BH.

Genet Mol Res. 2013 Jun 13;12(2):1924-33. doi: 10.4238/2013.June.13.1.

2.

Vascular endothelial growth factor +936C/T polymorphism and breast cancer risk: a meta-analysis of 13 case-control studies.

Yan Y, Liang H, Li T, Guo S, Li M, Li S, Qin X.

Tumour Biol. 2014 Mar;35(3):2687-92. doi: 10.1007/s13277-013-1354-2. Epub 2014 Jan 5.

3.

Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: a meta-analysis involving 16,703 individuals.

Wang K, Liu L, Zhu ZM, Shao JH, Xin L.

Cytokine. 2011 Nov;56(2):167-73. doi: 10.1016/j.cyto.2011.06.018. Epub 2011 Jul 27.

PMID:
21798757
4.

VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls.

Gu D, Wang M.

Breast Cancer Res Treat. 2011 Jan;125(2):489-93. doi: 10.1007/s10549-010-0991-z. Epub 2010 Jun 19.

PMID:
20563637
5.

Vascular endothelial growth factor 1498C/T, 936C/T polymorphisms associated with increased risk of colorectal adenoma: a Chinese case-control study.

Wu X, Li D, Liu Z, Wan X, Wu Y, Jiang C, Qian Q.

Mol Biol Rep. 2011 Mar;38(3):1949-55. doi: 10.1007/s11033-010-0316-7. Epub 2010 Sep 21.

PMID:
20857215
6.

Vascular endothelial growth factor +936C/T polymorphism and gastric cancer risk: A meta-analysis.

Zhou LP, Luan H, Dong XH, Jin GJ, Man DL, Shang H.

Exp Ther Med. 2011 Sep;2(5):931-936. Epub 2011 May 31.

7.

Current evidences on vascular endothelial growth factor polymorphisms and breast cancer susceptibility.

Qiu LX, Wang K, Yang S, Mao C, Zhao L, Yao L, Zhang J, Zhang QL, Sun S, Xue K.

Mol Biol Rep. 2011 Oct;38(7):4491-4. doi: 10.1007/s11033-010-0579-z. Epub 2010 Dec 2.

PMID:
21127992
8.

Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer.

Bae SJ, Ahn DH, Hong SP, Kang H, Hwang SG, Oh D, Kim NK.

Yonsei Med J. 2008 Oct 31;49(5):783-91. doi: 10.3349/ymj.2008.49.5.783.

9.

VEGFA+936C/T and -634G/C polymorphisms and gastric cancer risk: a meta-analysis.

Liu H, Wang S, Huang C.

Asian Pac J Cancer Prev. 2011;12(8):1979-83.

10.

Association of VEGF gene polymorphisms with advanced retinopathy of prematurity: a meta-analysis.

Liu P, Wu D, Zhou W, Li Y, Lian C, Yang Y, Feng Z.

Mol Biol Rep. 2012 Dec;39(12):10731-7. doi: 10.1007/s11033-012-1964-6. Epub 2012 Oct 13.

PMID:
23065202
11.

Assessment of the associations between three VEGF polymorphisms and risk of prostate cancer.

Chen GQ, Luo JB, Wang GZ, Ding JE.

Tumour Biol. 2014 Mar;35(3):1875-9. doi: 10.1007/s13277-013-1250-9. Epub 2013 Dec 19.

PMID:
24353087
12.

Polymorphism of VEGF-460C/T associated with the risk and clinical characteristics of lung cancer in Chinese population.

Sun SF, Huang DB, Cao C, Deng ZC.

Med Oncol. 2013 Mar;30(1):410. doi: 10.1007/s12032-012-0410-x. Epub 2013 Jan 4.

PMID:
23288726
13.

VEGF +936C/T and +460C/T gene polymorphisms and oral cancer risk: a meta-analysis.

Zhao SF, Zhan P, Yang XD, Lu MX, Sun GW, Wang YX, Zhang YK, Pu YM, Tang EY.

Mol Biol Rep. 2013 Dec;40(12):6637-43. doi: 10.1007/s11033-013-2778-x. Epub 2013 Sep 22.

PMID:
24057253
14.

Association of +405C>G and +936C>T polymorphisms of the vascular endothelial growth factor gene with sporadic breast cancer in North Indians.

Kapahi R, Manjari M, Sudan M, Uppal MS, Singh NR, Sambyal V, Guleria K.

Asian Pac J Cancer Prev. 2014;15(1):257-63.

15.

Vascular endothelial growth factor (VEGF) gene polymorphisms and colorectal cancer: a meta-analysis of epidemiologic studies.

Zhao Z, Ba C, Wang W, Wang X, Xue R, Wu X.

Genet Test Mol Biomarkers. 2012 Dec;16(12):1390-4. doi: 10.1089/gtmb.2012.0266. Epub 2012 Sep 24.

PMID:
23005896
16.

Four common vascular endothelial growth factor polymorphisms (-2578C>A, -460C>T, +936C>T, and +405G>C) in susceptibility to lung cancer: a meta-analysis.

Lin L, Cao K, Chen W, Pan X, Zhao H.

PLoS One. 2013 Oct 1;8(10):e75123. doi: 10.1371/journal.pone.0075123. eCollection 2013.

17.

Vascular endothelial growth factor (VEGF) gene polymorphisms and risk of head and neck cancer: a meta-analysis involving 2,444 individuals.

Leng WD, He MN, Chen QL, Gong H, Zhang L, Zeng XT.

Mol Biol Rep. 2013 Oct;40(10):5987-92. doi: 10.1007/s11033-013-2708-y. Epub 2013 Sep 21.

PMID:
24057180
18.

Quantitative assessment of the associations between CD28 T > C polymorphism (rs3116496) and cancer risk.

Cong J, Zhang S, Gao X.

Tumour Biol. 2014 Sep;35(9):9195-200. doi: 10.1007/s13277-014-2204-6. Epub 2014 Jun 14.

PMID:
24927673
19.

Vascular endothelial growth factor (VEGF) +936 C/T gene polymorphisms and gastric cancer risk: a meta-analysis involving 4,138 subjects.

Zhou Y, Hu W, Zhuang W, Liu GJ, Wu TX, Yao X, Du L, Wei ML, Wu XT.

Int J Biol Markers. 2010 Oct-Dec;25(4):213-8.

PMID:
21161943
20.

Vascular endothelial growth factor +936C/T, -634G/C, -2578C/A, and -1154G/A polymorphisms with risk of preeclampsia: a meta-analysis.

Cheng D, Hao Y, Zhou W, Ma Y.

PLoS One. 2013 Nov 4;8(11):e78173. doi: 10.1371/journal.pone.0078173. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk